Maximizing Pharmaceutical Licensing Opportunities

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

CSPC Pharmaceutical Group Ltd

CSPC Pharmaceutical Group Ltd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • August 2014
  • 56 pages

A textual analysis of the financial results for CSPC Pharmaceutical Group Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Pharmaceutical | Countries: China

Indoco Remedies Ltd

Indoco Remedies Ltd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • August 2014
  • 55 pages

A textual analysis of the financial results for Indoco Remedies Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Drug and Medication

Sms Pharmaceuticals Limited

Sms Pharmaceuticals Limited

  • $ 55
  • Company report
  • by Wright Investors' Service
  • August 2014
  • 55 pages

A textual analysis of the financial results for Sms Pharmaceuticals Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Pharmaceutical

Korean Drug Co Ltd

Korean Drug Co Ltd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • August 2014
  • 56 pages

A textual analysis of the financial results for Korean Drug Co Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Drug and Medication | Countries: South Korea

Australia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Australia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • August 2014
  • 135 pages

BMI View: Australian prospects for multinational drugmakers are mixed. In the first quarter of the year it was announced that eight medicines would not be included in the country's Pharmaceutical Benefits Scheme (PBS), which accounts for 75% of medicine spending, until 2013. On a more positive note, ...

Industries: Drug and Medication | Countries: Australia

Croatia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Croatia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • August 2014
  • 102 pages

BMI View: Croatia’s pharmaceutical industry appears relatively stable, recording 0.1% growth in 2010 – a year in which economic challenges were sizeable. Compared with its south eastern European neighbours, Croatia ranks relatively highly in terms of pharmaceutical consumption. In 2010, BMI calculates ...

Industries: Pharmaceutical | Countries: Croatia

Mexico Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Mexico Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • August 2014
  • 144 pages

BMI View: Building on rapid expansion over the past five years, Latin America's pharmaceutical industry will record stronger medium-term growth, driven by the introduction of new products for the region's ageing population. However, Mexico looks set to suffer as persistent shortcomings in policy harmonisation ...

Industries: Generic Drug | Countries: Mexico

Kenya Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Kenya Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • August 2014
  • 106 pages

BMI View: The Kenyan pharmaceuticals and healthcare industry presents significant revenue earning opportunities for drug firms . Growth in the segment will be boosted by strong demographics, increased healthcare needs, longer life expectancy, increased healthcare spending in the public and private segments ...

Industries: Drug and Medication | Countries: Kenya

Algeria Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Algeria Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • August 2014
  • 101 pages

BMI View: Algeria is currently a high-risk industry for multinational drugmakers because of the combination of regional political uncertainty and state interference in its business environment. The country's protectionist import policies, together with its failure to anticipate consumer demands, are ...

Industries: Pharmaceutical | Countries: Algeria

Latvia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Latvia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • August 2014
  • 107 pages

BMI View: Latvia's disease profile and relatively low per-capita consumption of pharmaceuticals (compared with the rest of developed Europe) is a clear illustration of the need for innovative medicines. However, the performance of the pharmaceutical industry remains indelibly tied to the country's macroeconomic ...

Industries: Drug and Medication | Countries: Latvia

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.